State-certified doctor of pharmacy, the university career of Jeremie LE GOFF is complemented by a PhD in Molecular Biology from the University of Caen / Basse-Normandie (2000-2004).
This orientation towards the Scientific Research has been the opportunity to improve its skill level and experience in the fields of Oncology and Toxicology.
After a first step of forming at the Institut Curie of Orsay, jeremie LE GOFF has developed locally the 32P post-labeling technique, a sensitive method in the research for DNA adducts. He eventually founded the company in 2010.
Meeting the demand for new approaches to biological risk assessment, Jeremie LE GOFF initiated a valorization work which eventually led to create ADn'tox.